Exact Mass: 632.4149

Exact Mass Matches: 632.4149

Found 93 metabolites which its exact mass value is equals to given mass value 632.4149, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Methyl helicterate

Methyl 17-(acetyloxy)-2-[(benzoyloxy)methyl]-1,14,18,18-tetramethyl-8-(prop-1-en-2-yl)pentacyclo[11.8.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]henicosane-5-carboxylic acid

C40H56O6 (632.4077)


   

PA(12:0/18:1(12Z)-O(9S,10R))

[(2R)-3-(dodecanoyloxy)-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C33H61O9P (632.4053)


PA(12:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(12:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one dodecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(12Z)-O(9S,10R)/12:0)

[(2R)-2-(dodecanoyloxy)-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C33H61O9P (632.4053)


PA(18:1(12Z)-O(9S,10R)/12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/12:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of dodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(12:0/18:1(9Z)-O(12,13))

[(2R)-3-(dodecanoyloxy)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C33H61O9P (632.4053)


PA(12:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(12:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one dodecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(9Z)-O(12,13)/12:0)

[(2R)-2-(dodecanoyloxy)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C33H61O9P (632.4053)


PA(18:1(9Z)-O(12,13)/12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/12:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of dodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(i-12:0/18:1(12Z)-O(9S,10R))

PA(i-12:0/18:1(12Z)-O(9S,10R))

C33H61O9P (632.4053)


PA(i-12:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-12:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(12Z)-O(9S,10R)/i-12:0)

[(2R)-2-[(10-methylundecanoyl)oxy]-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C33H61O9P (632.4053)


PA(18:1(12Z)-O(9S,10R)/i-12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/i-12:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(i-12:0/18:1(9Z)-O(12,13))

[(2R)-3-[(10-methylundecanoyl)oxy]-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C33H61O9P (632.4053)


PA(i-12:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-12:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(9Z)-O(12,13)/i-12:0)

[(2R)-2-[(10-methylundecanoyl)oxy]-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C33H61O9P (632.4053)


PA(18:1(9Z)-O(12,13)/i-12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/i-12:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

19-Hydroxyfucoxanthinol

(3S,3S,5R,5R,6S,6R)-6,7-Didehydro-5,6-epoxy-5,6,6,7-tetrahydro-3,3,5,19-tetrahydroxy-beta,beta-caroten-8(5H)-one

C40H56O6 (632.4077)


   

Lawsonic acid

(+)-Lawsonic acid

C40H56O6 (632.4077)


   

Scaphopetalumate

Scaphopetalumate

C40H56O6 (632.4077)


   

Methylene-bismehranine

(-)-Methylene-bismehranine

C41H52N4O2 (632.409)


   
   

taiwaniadduct E

taiwaniadduct E

C40H56O6 (632.4077)


   

Methyl helicterate

Methyl helicterate

C40H56O6 (632.4077)


   

3-O-(E)-feruloylursolic acid|3-O-beta-feruloyl-ursolic acid|3-O-[(E)-feruloyl]ursolic acid

3-O-(E)-feruloylursolic acid|3-O-beta-feruloyl-ursolic acid|3-O-[(E)-feruloyl]ursolic acid

C40H56O6 (632.4077)


   

Methyl helicterilate

Methyl helicterilate

C40H56O6 (632.4077)


   
   

taiwaniadduct B

taiwaniadduct B

C40H56O6 (632.4077)


   

taiwaniadduct D

taiwaniadduct D

C40H56O6 (632.4077)


   

3beta-hydroxy-21beta-E-p-methoxycinnamoylIoxyolean-12-en-28-oic acid

3beta-hydroxy-21beta-E-p-methoxycinnamoylIoxyolean-12-en-28-oic acid

C40H56O6 (632.4077)


   

(4S,5E,12aS)-12-{[(1R,4aS,5S,8aS)-5-carboxy-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]methyl}-6-formyl-1,3,4,4a,7,8,8a,9,10,13,14,14a-dodecahydro-11-methyl-1-methylidene-10-oxo-4-(propan-2-yl)dibenzo[a,e] [10]annulene-12a(2H)-carboxylic acid|Bisyinshanic Acid A

(4S,5E,12aS)-12-{[(1R,4aS,5S,8aS)-5-carboxy-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]methyl}-6-formyl-1,3,4,4a,7,8,8a,9,10,13,14,14a-dodecahydro-11-methyl-1-methylidene-10-oxo-4-(propan-2-yl)dibenzo[a,e] [10]annulene-12a(2H)-carboxylic acid|Bisyinshanic Acid A

C40H56O6 (632.4077)


   

(3alpha)-3-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}olean-12-en-27-oic acid|3alpha-O-feruloylolean-12-en-27-oic acid

(3alpha)-3-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}olean-12-en-27-oic acid|3alpha-O-feruloylolean-12-en-27-oic acid

C40H56O6 (632.4077)


   

taiwaniadduct C

taiwaniadduct C

C40H56O6 (632.4077)


   

Jacoumarsaeuremethylester

Jacoumarsaeuremethylester

C40H56O6 (632.4077)


   

Methyl 9-acetyloxy-5a-(benzoyloxymethyl)-5b,8,8,11a-tetramethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

Methyl 9-acetyloxy-5a-(benzoyloxymethyl)-5b,8,8,11a-tetramethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C40H56O6 (632.4077)


   

PA(12:0/18:1(12Z)-O(9S,10R))

PA(12:0/18:1(12Z)-O(9S,10R))

C33H61O9P (632.4053)


   

PA(18:1(12Z)-O(9S,10R)/12:0)

PA(18:1(12Z)-O(9S,10R)/12:0)

C33H61O9P (632.4053)


   

PA(i-12:0/18:1(12Z)-O(9S,10R))

PA(i-12:0/18:1(12Z)-O(9S,10R))

C33H61O9P (632.4053)


   

PA(18:1(12Z)-O(9S,10R)/i-12:0)

PA(18:1(12Z)-O(9S,10R)/i-12:0)

C33H61O9P (632.4053)


   

PA(i-12:0/18:1(9Z)-O(12,13))

PA(i-12:0/18:1(9Z)-O(12,13))

C33H61O9P (632.4053)


   

PA(18:1(9Z)-O(12,13)/i-12:0)

PA(18:1(9Z)-O(12,13)/i-12:0)

C33H61O9P (632.4053)


   

[(2R)-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropyl] dodecanoate

[(2R)-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropyl] dodecanoate

C33H61O9P (632.4053)


   

[(2R)-1-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] dodecanoate

[(2R)-1-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] dodecanoate

C33H61O9P (632.4053)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] undecanoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] undecanoate

C33H61O9P (632.4053)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C33H61O9P (632.4053)


   
   
   

PA O-18:0/12:3;O2

PA O-18:0/12:3;O2

C33H61O9P (632.4053)


   
   

PA P-18:0/12:2;O2

PA P-18:0/12:2;O2

C33H61O9P (632.4053)


   

PA 22:1/8:1;O

PA 22:1/8:1;O

C33H61O9P (632.4053)


   
   
   
   

(4as,6br,10r,12as,12br,14as)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2,2,6b,9,9,12a,12b,14a-octamethyl-3,4,5,7,8,8a,10,11,12,13,14,14b-dodecahydro-1h-picene-4a-carboxylic acid

(4as,6br,10r,12as,12br,14as)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2,2,6b,9,9,12a,12b,14a-octamethyl-3,4,5,7,8,8a,10,11,12,13,14,14b-dodecahydro-1h-picene-4a-carboxylic acid

C40H56O6 (632.4077)


   

(2r,4as)-2-{[(2r,4as)-4-[2-(furan-3-yl)ethyl]-4-hydroxy-3,4a,8,8-tetramethyl-1-oxo-hexahydronaphthalen-2-yl]oxy}-4-[2-(furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-5,6,7,8a-tetrahydro-2h-naphthalen-1-one

(2r,4as)-2-{[(2r,4as)-4-[2-(furan-3-yl)ethyl]-4-hydroxy-3,4a,8,8-tetramethyl-1-oxo-hexahydronaphthalen-2-yl]oxy}-4-[2-(furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-5,6,7,8a-tetrahydro-2h-naphthalen-1-one

C40H56O6 (632.4077)


   

n-[1-({1-[(1-methoxy-3-methyl-1-oxopentan-2-yl)(methyl)carbamoyl]-2-(4-methoxyphenyl)ethyl}(methyl)carbamoyl)-2-methylpropyl]-3-methyl-2-(n-methylbutanamido)butanimidic acid

n-[1-({1-[(1-methoxy-3-methyl-1-oxopentan-2-yl)(methyl)carbamoyl]-2-(4-methoxyphenyl)ethyl}(methyl)carbamoyl)-2-methylpropyl]-3-methyl-2-(n-methylbutanamido)butanimidic acid

C34H56N4O7 (632.4149)


   

(2s,4as,8as)-2-{[(2r,3r,4r,4as,8as)-4-[2-(furan-3-yl)ethyl]-4-hydroxy-3,4a,8,8-tetramethyl-1-oxo-hexahydronaphthalen-2-yl]oxy}-4-[2-(furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-5,6,7,8a-tetrahydro-2h-naphthalen-1-one

(2s,4as,8as)-2-{[(2r,3r,4r,4as,8as)-4-[2-(furan-3-yl)ethyl]-4-hydroxy-3,4a,8,8-tetramethyl-1-oxo-hexahydronaphthalen-2-yl]oxy}-4-[2-(furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-5,6,7,8a-tetrahydro-2h-naphthalen-1-one

C40H56O6 (632.4077)


   

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[(3z)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[(3z)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C40H56O6 (632.4077)


   

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C40H56O6 (632.4077)


   

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-{[(2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-{[(2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C40H56O6 (632.4077)


   

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C40H56O6 (632.4077)


   

(4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[(3e)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[(3e)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C40H56O6 (632.4077)


   

10-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

10-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C40H56O6 (632.4077)


   

(1s,6s,11s,19s,23s)-6,28-dihydroxy-1,16-diisopropyl-10,10,24,24-tetramethyl-2,18-dioxaheptacyclo[17.13.0.0³,¹⁷.0⁴,¹⁴.0⁶,¹¹.0²⁰,³⁰.0²³,²⁸]dotriaconta-3(17),4(14),15,20(30)-tetraene-31,32-dione

(1s,6s,11s,19s,23s)-6,28-dihydroxy-1,16-diisopropyl-10,10,24,24-tetramethyl-2,18-dioxaheptacyclo[17.13.0.0³,¹⁷.0⁴,¹⁴.0⁶,¹¹.0²⁰,³⁰.0²³,²⁸]dotriaconta-3(17),4(14),15,20(30)-tetraene-31,32-dione

C40H56O6 (632.4077)


   

6,28-dihydroxy-1,16-diisopropyl-10,10,24,24-tetramethyl-2,18-dioxaheptacyclo[17.13.0.0³,¹⁷.0⁴,¹⁴.0⁶,¹¹.0²⁰,³⁰.0²³,²⁸]dotriaconta-3(17),4(14),15,20(30)-tetraene-31,32-dione

6,28-dihydroxy-1,16-diisopropyl-10,10,24,24-tetramethyl-2,18-dioxaheptacyclo[17.13.0.0³,¹⁷.0⁴,¹⁴.0⁶,¹¹.0²⁰,³⁰.0²³,²⁸]dotriaconta-3(17),4(14),15,20(30)-tetraene-31,32-dione

C40H56O6 (632.4077)


   

(1r,4ar,5s,8ar)-5-{[(1r,2s,7s,8r,9s,10r)-8-formyl-15-hydroxy-16-isopropyl-2,6,6,11-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-10-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1r,4ar,5s,8ar)-5-{[(1r,2s,7s,8r,9s,10r)-8-formyl-15-hydroxy-16-isopropyl-2,6,6,11-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-10-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

[(1r,3as,5as,5br,7ar,9s,11ar,11br,13ar,13br)-9-(acetyloxy)-3a-(methoxycarbonyl)-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-5a-yl]methyl benzoate

[(1r,3as,5as,5br,7ar,9s,11ar,11br,13ar,13br)-9-(acetyloxy)-3a-(methoxycarbonyl)-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-5a-yl]methyl benzoate

C40H56O6 (632.4077)


   

(1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C40H56O6 (632.4077)


   

(1r,3as,5ar,5br,7as,9s,11ar,11bs,13ar,13br)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1r,3as,5ar,5br,7as,9s,11ar,11bs,13ar,13br)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C40H56O6 (632.4077)


   

(1r,3as,5ar,5br,7ar,9r,11ar,11br,13ar,13br)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1r,3as,5ar,5br,7ar,9r,11ar,11br,13ar,13br)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C40H56O6 (632.4077)


   

5-(3-{2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-14-yl}but-2-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

5-(3-{2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-14-yl}but-2-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

(3e,5e,7e,9e,11e,13e,15z)-18-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-16-(hydroxymethyl)-3,7,12-trimethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

(3e,5e,7e,9e,11e,13e,15z)-18-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-16-(hydroxymethyl)-3,7,12-trimethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O6 (632.4077)


   

(1r,3as,5ar,7ar,9s,11as,11br,13ar,13bs)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1r,3as,5ar,7ar,9s,11as,11br,13ar,13bs)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C40H56O6 (632.4077)


   

[9-(acetyloxy)-3a-(methoxycarbonyl)-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-5a-yl]methyl benzoate

[9-(acetyloxy)-3a-(methoxycarbonyl)-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-5a-yl]methyl benzoate

C40H56O6 (632.4077)


   

methyl 11-hydroxy-10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

methyl 11-hydroxy-10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C40H56O6 (632.4077)


   

(1r,4ar,5s,8ar)-5-[(2e)-3-[(1s,2r,3s,8s,12s,14r)-2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-14-yl]but-2-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1r,4ar,5s,8ar)-5-[(2e)-3-[(1s,2r,3s,8s,12s,14r)-2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-14-yl]but-2-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C40H56O6 (632.4077)


   

(1r,3as,5ar,5br,9s,11ar)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1r,3as,5ar,5br,9s,11ar)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C40H56O6 (632.4077)


   

5-(3-{2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-13-yl}but-2-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

5-(3-{2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-13-yl}but-2-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C40H56O6 (632.4077)


   

(1r,3as,5ar,5br,7ar,9s,11as,11br,13ar,13bs)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

(1r,3as,5ar,5br,7ar,9s,11as,11br,13ar,13bs)-9-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C40H56O6 (632.4077)


   

(1r,4ar,5s,8ar)-5-{[(1s,2s,7s,8r,10r,12s,17s)-9,15-dihydroxy-14-isopropyl-2,6,6-trimethyl-18-methylidene-13,16-dioxopentacyclo[8.6.2.0¹,¹².0²,⁷.0⁸,¹²]octadec-14-en-17-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1r,4ar,5s,8ar)-5-{[(1s,2s,7s,8r,10r,12s,17s)-9,15-dihydroxy-14-isopropyl-2,6,6-trimethyl-18-methylidene-13,16-dioxopentacyclo[8.6.2.0¹,¹².0²,⁷.0⁸,¹²]octadec-14-en-17-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

(1r,4ar,5s,8ar)-5-{[(1r,2s,7s,8r,9s,10s,12s,17s)-9,15-dihydroxy-14-isopropyl-2,6,6-trimethyl-18-methylidene-13,16-dioxopentacyclo[8.6.2.0¹,¹².0²,⁷.0⁸,¹²]octadec-14-en-17-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1r,4ar,5s,8ar)-5-{[(1r,2s,7s,8r,9s,10s,12s,17s)-9,15-dihydroxy-14-isopropyl-2,6,6-trimethyl-18-methylidene-13,16-dioxopentacyclo[8.6.2.0¹,¹².0²,⁷.0⁸,¹²]octadec-14-en-17-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

(1r,4ar,5s,8ar)-5-{[(1r,2s,7s,8r,9s,10r)-8-formyl-15-hydroxy-16-isopropyl-2,6,6,12-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-10-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1r,4ar,5s,8ar)-5-{[(1r,2s,7s,8r,9s,10r)-8-formyl-15-hydroxy-16-isopropyl-2,6,6,12-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-10-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

(2s)-n-[(1s)-1-{[(1s)-1-{[(2s,3s)-1-methoxy-3-methyl-1-oxopentan-2-yl](methyl)carbamoyl}-2-(4-methoxyphenyl)ethyl](methyl)carbamoyl}-2-methylpropyl]-3-methyl-2-(n-methylbutanamido)butanimidic acid

(2s)-n-[(1s)-1-{[(1s)-1-{[(2s,3s)-1-methoxy-3-methyl-1-oxopentan-2-yl](methyl)carbamoyl}-2-(4-methoxyphenyl)ethyl](methyl)carbamoyl}-2-methylpropyl]-3-methyl-2-(n-methylbutanamido)butanimidic acid

C34H56N4O7 (632.4149)


   

5-({8-formyl-15-hydroxy-16-isopropyl-2,6,6,12-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-10-yl}methyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

5-({8-formyl-15-hydroxy-16-isopropyl-2,6,6,12-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-10-yl}methyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

10-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

10-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C40H56O6 (632.4077)


   

5-({8-formyl-15-hydroxy-16-isopropyl-2,6,6,12-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-13-yl}methyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

5-({8-formyl-15-hydroxy-16-isopropyl-2,6,6,12-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-13-yl}methyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[(3e)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[(3e)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C40H56O6 (632.4077)


   

(1r,4ar,5s,8ar)-5-{[(1r,2s,7s,8r,9s,13s)-8-formyl-15-hydroxy-16-isopropyl-2,6,6,12-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-13-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1r,4ar,5s,8ar)-5-{[(1r,2s,7s,8r,9s,13s)-8-formyl-15-hydroxy-16-isopropyl-2,6,6,12-tetramethyl-14,17-dioxotetracyclo[7.4.4.0¹,⁹.0²,⁷]heptadeca-11,15-dien-13-yl]methyl}-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

9-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

9-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C40H56O6 (632.4077)


   

methyl (1r,2r,4ar,6as,6br,8as,10r,11r,12ar,12bs,14br)-11-hydroxy-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

methyl (1r,2r,4ar,6as,6br,8as,10r,11r,12ar,12bs,14br)-11-hydroxy-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C40H56O6 (632.4077)


   

(1r,4ar,5s,8ar)-5-[(2e)-3-[(1s,2r,3s,8s,12r,13s)-2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-13-yl]but-2-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1r,4ar,5s,8ar)-5-[(2e)-3-[(1s,2r,3s,8s,12r,13s)-2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-13-yl]but-2-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

(1s,6s,11s,19s,23s,28s)-6,28-dihydroxy-1,16-diisopropyl-10,10,24,24-tetramethyl-2,18-dioxaheptacyclo[17.13.0.0³,¹⁷.0⁴,¹⁴.0⁶,¹¹.0²⁰,³⁰.0²³,²⁸]dotriaconta-3(17),4(14),15,20(30)-tetraene-31,32-dione

(1s,6s,11s,19s,23s,28s)-6,28-dihydroxy-1,16-diisopropyl-10,10,24,24-tetramethyl-2,18-dioxaheptacyclo[17.13.0.0³,¹⁷.0⁴,¹⁴.0⁶,¹¹.0²⁰,³⁰.0²³,²⁸]dotriaconta-3(17),4(14),15,20(30)-tetraene-31,32-dione

C40H56O6 (632.4077)


   

4-[2-(furan-3-yl)ethyl]-2-({4-[2-(furan-3-yl)ethyl]-4-hydroxy-3,4a,8,8-tetramethyl-1-oxo-hexahydronaphthalen-2-yl}oxy)-3,4a,8,8-tetramethyl-5,6,7,8a-tetrahydro-2h-naphthalen-1-one

4-[2-(furan-3-yl)ethyl]-2-({4-[2-(furan-3-yl)ethyl]-4-hydroxy-3,4a,8,8-tetramethyl-1-oxo-hexahydronaphthalen-2-yl}oxy)-3,4a,8,8-tetramethyl-5,6,7,8a-tetrahydro-2h-naphthalen-1-one

C40H56O6 (632.4077)


   

(1r,4ar,5s,8ar)-5-[(2z)-3-[(1s,2r,3s,8s,12s,14r)-2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-14-yl]but-2-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

(1r,4ar,5s,8ar)-5-[(2z)-3-[(1s,2r,3s,8s,12s,14r)-2-formyl-10-hydroxy-12-isopropyl-4,4,8-trimethyl-11,15-dioxotetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadec-9-en-14-yl]but-2-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

5-({9,15-dihydroxy-14-isopropyl-2,6,6-trimethyl-18-methylidene-13,16-dioxopentacyclo[8.6.2.0¹,¹².0²,⁷.0⁸,¹²]octadec-14-en-17-yl}methyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

5-({9,15-dihydroxy-14-isopropyl-2,6,6-trimethyl-18-methylidene-13,16-dioxopentacyclo[8.6.2.0¹,¹².0²,⁷.0⁸,¹²]octadec-14-en-17-yl}methyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H56O6 (632.4077)


   

(9e,11e,13e,15z)-18-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-1-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-16-(hydroxymethyl)-3,7,12-trimethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

(9e,11e,13e,15z)-18-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-1-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-16-(hydroxymethyl)-3,7,12-trimethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O6 (632.4077)